Search

Filters
Clear All
  • 49
  • 59
  • 6
  • 3
  • 497

Phase

  • 18
  • 14
  • 3
  • 14
  • 6
  • 15
  • 2
  • 439
  • 580
  • 230
  • 603
  • 11
  • 53
  • 26
  • 6
  • 608

Found 614 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 100 years
All genders
The purpose of this research study is to learn more about the safety and anti-cancer activity of a 3-drug combination therapy involving antibodies nivolumab, ipilimumab and panitumumab.
18 years - 100 years
All genders
The purpose of this study is to compare any good and bad effects of using a high dose Interleukin (IL-2) and Entinostat to using IL-2 alone. The addition of Entinostat to high dose IL-2 could shrink your cancer/prevent it from returning for a longer period of time but it could …
18 years - 100 years
All genders
This randomized phase III trial compares nephrectomy (surgery to remove a kidney or part of a kidney) with or without nivolumab in treating patients with kidney cancer that is limited to a certain part of the body (localized).
18 years - 24 years
All genders
This study will investigate the perception of regional dialects including listeners' abilities to classify the dialects into groups and rate speakers from various dialect regions in a language attitudes task.
18 years - 100 years
All genders
This phase II trial studies how well atezolizumab works in treating patients with non-muscle invasive bladder cancer that has come back and has not responded to treatment with Bacillus Calmette-Guerin (BCG).
18 years - 100 years
All genders
The goal of this project is to secure lung, tissue and blood samples of no clinical or diagnostic value from patients with cystic fibrosis (CF), and provide them to qualified and approved medical researchers.
18 years - 100 years
Female
The purpose of this study is to understand how parents make decisions during pregnancy and after the birth of their new baby.
18 years - 100 years
All genders
This is a Phase 1, open label, multi-center study of orally administered DSP-0337 in adult subjects with advance solid tumors that are refractory to standard treatment, or for whom no effective therapy exists.
18 years - 100 years
All genders
This study is being done to see what effects the combination of pembrolizumab and carboplatin have on breast cancer compared to carboplatin alone.
1 years - 30 years
All genders
The purpose of this study is to look at iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma.